Navigating the Landscape of Mineralocorticoid Receptor Antagonists Therapy

Описание к видео Navigating the Landscape of Mineralocorticoid Receptor Antagonists Therapy

Mineralocortiooid receptor antagonists (MRAs) are still largely underused in clinical practice. Faiez Zannad, MD, PhD, will discuss the rationale behind the use of MRAs in heart failure with reduced ejection fraction.

Zannad has contributed to landmark clinical trials. He was the first to suggest that spironolactone may be added to angiotensin-converting inhibitors to improve outcomes in patients with heart failure.

Комментарии

Информация по комментариям в разработке

Похожие видео